BlackRock
CPXX

BlackRock’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

BlackRock’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,457
Closed -$74K – 3834
2016
Q2 		$74K Buy
+2,457
New +$49.9K ﹤0.01% 2733

BlackRock's CPXX Position: Q3 2016 in Review

BlackRock sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 2,457 shares — an estimated $74K sold.

BlackRock first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $74K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • BlackRock reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • BlackRock sold 2,457 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $74K.
  • BlackRock first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • BlackRock's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $74K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on BlackRock's 13F filing for Q3 2016, filed 8 Nov 2016.